rs11706494 - NXPE3
Magnitude 2.2 · 1 study on file
Reported associations
-
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 - Unknown journal (n.d.) · Unknown authors · PubMed 37198478
ABSTRACT: Critical illness in COVID-19 is an extreme and clinically homogeneous disease phenotype that we have previously shown to be highly efficient for discovery of genetic associations. Despite the advanced stage of illness at presentation, we have shown that host genetics in patients who are critically ill with COVID-19 can identify immunomodulatory therapies with strong beneficial effects in this group. Here we analyse 24,202 cases of COVID-19 with critical illness comprising a combination of microarray genotype and whole-genome sequencing data from cases of critical illness in the international GenOMICC (11,440 cases) study, combined with other studies recruiting hospitalized patients with a strong focus on severe and critical disease: ISARIC4C (676 cases) and the SCOURGE consortium
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
genetic risk assessment for COVID-19 severity High
rs11706494-A allele is genome-wide significantly associated with 1.1-fold increased odds of critical illness if SARS-CoV-2 infected
review personalized COVID-19 prevention strategy and discuss early treatment options if exposed or symptomatic
Lifestyle
-
enhanced COVID-19 prevention measures High
rs11706494-A carriers have 1.1-fold higher odds of critical illness if infected with SARS-CoV-2; prevention reduces infection risk
use masks in crowded settings, improve home ventilation, isolate when symptomatic, maintain vaccination
Screening
-
early COVID-19 symptom recognition High
rs11706494-A carriers progress to critical illness more readily if infected; prompt intervention may mitigate severity
seek immediate medical evaluation for respiratory symptoms, fever, or fatigue if COVID-19 suspected